More Globe Newswire

View Older Stories View Newer Stories

Oct 7, 2026 08:00AM Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
Oct 7, 2026 08:00AM American Fusion Restructures Up to $2.88 Million of Stock-Based Compensation Obligations into Long-Term, Lock-Up Preferred Equity and Begins Auditor Transition to MBP Global LLP
Oct 7, 2026 08:00AM SEON Appoints Ken Talanian as Chief Financial Officer
Oct 7, 2026 08:00AM Magnum York and C-Era Tee Up to Support Families in Crisis Through Associa Cares Canada
Oct 7, 2026 08:00AM Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum
Oct 7, 2026 08:00AM Esperion Reaches Settlement Agreement with Sixth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
Oct 7, 2026 08:00AM Melissa Introduces Elected Officials Data for More Effective Government Relations and Advocacy
Oct 7, 2026 08:00AM Erin Schaefer, Former Google/YouTube Senior Executive, Joins Roundtable Board to Help Guide Premium-Media OS Growth
Oct 7, 2026 08:00AM Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease
Oct 7, 2026 08:00AM AMLM Announces Conversion of Worldwide Diversified Holdings, Inc. Note into Common Shares, Strengthening Balance Sheet and Expanding Shareholder Base
Oct 7, 2026 08:00AM Healthrise Identifies Key Factors for a Faster, More Efficient EHR Go-Live
Oct 7, 2026 08:00AM Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
Oct 7, 2026 08:00AM Kaléo Awarded $96.1 Million BARDA Contract to Advance 2-PAM Auto-Injector for U.S. Chemical Threat Preparedness
Oct 7, 2026 08:00AM Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026
Oct 7, 2026 08:00AM Aptean Launches Ascent, an Outcome-Based AI Partnership Built on Measurable Business Results
Oct 7, 2026 08:00AM Madison Realty Capital Provides Loan for Hotel Washington in Washington, D.C.
Oct 7, 2026 08:00AM WillScot Elects Donald Slager to Board of Directors
Oct 7, 2026 08:00AM ZeroMe Launches OffsetC App to Bring Transparency and Personal Agency to Carbon Offsetting
Oct 7, 2026 08:00AM Clearsense Introduces Cloud Medical Image Archive to Reduce Infrastructure and Storage Costs
Oct 7, 2026 08:00AM Virtu Financial to Host Conference Call Announcing Third Quarter 2026 Results on Thursday, November 5, 2026
Oct 7, 2026 08:00AM Bexorg Awarded Up to $28.3 Million from ARPA-H to Advance Human Brain Translational Pharmacology for CNS Drug Development
Oct 7, 2026 08:00AM Texas Capital Bancshares, Inc. Announces Date for Q3 2026 Operating Results
Oct 7, 2026 08:00AM Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home
Oct 7, 2026 08:00AM Skyharbour Commences Drilling at the Getty East Uranium Joint Venture with Partner Denison Mines at the Russell Lake Project Area
Oct 7, 2026 08:00AM Nuclear Waste Innovator Deep Isolation to Present at Three Upcoming Investor Conferences
Oct 7, 2026 08:00AM Sunrun Announces Date for Third Quarter 2026 Earnings Report
Oct 7, 2026 08:00AM Rezera Announces Positive RESOLVE-2 Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile for Ruvonoflast in Combination with Semaglutide
Oct 7, 2026 08:00AM Esperion Reaches Settlement Agreement with Sixth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
Oct 7, 2026 07:55AM Bitcoin Learns to Move: IBVM Lists on MEXC as TOKEN2049 Comes to Singapore
Oct 7, 2026 07:55AM New MIT Sloan research finds a “Bamboo Ceiling” for ethnic Chinese men in the UK
Oct 7, 2026 07:45AM Mobilicom to Unveil New Solution and Showcase Cybersecure Portfolio at AUSA 2026; Company to Present at ThinkEquity Investor Conference
Oct 7, 2026 07:32AM Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud
Oct 7, 2026 07:30AM New Purpose Unlimited research reveals Canadians are more financially ambitious than the system they’ve been handed
Oct 7, 2026 07:30AM Volatus Aerospace Completes the Initial ISR Drone Fleet Delivery to NATO Partner
Oct 7, 2026 07:30AM Hillman Sets Third Quarter 2026 Earnings Release and Results Presentation Date
Oct 7, 2026 07:30AM Crane NXT Appoints Jeong H. Kim to Board of Directors
Oct 7, 2026 07:30AM Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets
Oct 7, 2026 07:30AM Atlantic HPC Group Inc Appoints Leo Lin as Chief Executive Officer
Oct 7, 2026 07:30AM Sportradar Announces Agreement for the Divestiture of Coaching and Scouting Business of Synergy Sports to Teamworks Innovations
Oct 7, 2026 07:24AM BrewDog Rallies Beer Lovers Across the UK to Choose Craft
Oct 7, 2026 07:15AM Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes
Oct 7, 2026 07:13AM ProVen Growth and Income VCT plc: Issue of Equity and Closure of Offer for Subscription
Oct 7, 2026 07:13AM Form 8.3 - Ramsdens Holdings Plc
Oct 7, 2026 07:11AM ProVen VCT plc: Issue of Equity and Closure of Offer for Subscription
Oct 7, 2026 07:08AM CHARM Therapeutics announces first patient dosed and first cohort fully enrolled in its Phase I/II clinical trial of CHM-029 for Acute Myeloid Leukemia
Oct 7, 2026 07:05AM Gilat Secures Over $10 Million in Additional SkyEdge IV Orders from a Leading Satellite Operator
Oct 7, 2026 07:05AM Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026
Oct 7, 2026 07:05AM OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX
Oct 7, 2026 07:05AM Lantronix CEO to Meet with Investors and Defense Customers at AUSA 2026
Oct 7, 2026 07:05AM Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis
View Newer Stories View Older Stories